India, Oct. 22 -- Climate biotech innovator Brevel, Ltd. signed a 50/50 joint-venture agreement with India-based conglomerate The Wave Group. The collaboration will open a full-production biomanufacturing facility, funded by The Wave Group, based on Brevel's illuminated fermentation technology. The signing took place at an official ceremony in New Delhi attended by the Deputy Head of Mission of the Embassy of Israel and representatives of the Economic and Trade Mission of Israel, together with India government officials from Invest India.

The planned new manufacturing site in Uttar Pradesh, North India, represents a major scale-up from Brevel's existing 5,000-liter capacity bioreactor in its current commercial facility in Israel. The new...